• Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives Consensus Recommendation of "Moderate Buy" from Analysts

    Source: Buzz FX / 24 Nov 2024 03:46:08   America/Chicago


    Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives Consensus Recommendation of "Moderate Buy" from Analysts Written by MarketBeat November 24, 2024 Share Link copied to clipboard. Rhythm Pharmaceuticals, Inc.
    Read more...
Share on,